ArticleImmunotherapy advances2023

Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood.

Meiyin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.